Side-by-side comparison of AI visibility scores, market position, and capabilities
Nursa connects 400,000+ verified clinicians (RNs, LPNs, CNAs) with facilities for flexible PRN shifts; raised $103M (Series B led by Drive Capital); launched AI scheduling in September 2025; serves facilities nationwide.
Nursa is a Salt Lake City-based healthcare staffing platform that connects nurses and other healthcare professionals with hospitals, nursing homes, and care facilities that need short-term clinical staff. The platform offers verified clinicians — including Registered Nurses (RNs), Licensed Practical Nurses (LPNs), and Certified Nursing Assistants (CNAs) — the ability to browse and book PRN (as-needed) shifts on flexible schedules, giving them income control without the constraints of traditional agency placement. For facilities, Nursa provides on-demand access to a pool of over 400,000 verified, local clinicians to fill staffing gaps quickly and cost-effectively.
mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.
Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.